06/10/2006

Call to vaccinate schoolgirls over sex virus

All schoolgirls should be vaccinated against the sexually transmitted virus that causes cervical cancer, a medical journal has said.

The Lancet has called for compulsory vaccinations against human papillomavirus for girls aged 11 or 12 in the UK, like the US state of Michigan.

However, there have been fears that the vaccine could encourage under-age sex.

The European Commission licensed the first anti-HPV vaccine - Gardasil - last week, allowing it to be used on nine to 26-year-olds.

The vaccine provides protection against the two types of HPV which are responsible for 70% of cervical cancers and two other strands which are responsible for around 90% of genital warts.

The Lancet also suggested that boys should be immunised against the virus, because both men and women can carry it.

(KMcA/EF)

Related UK National News Stories
Click here for the latest headlines.

07 August 2003
Breakthrough vaccine could protect against Ebola virus
In a breakthrough discovery, it has been revealed that scientists in the US have developed a single shot vaccine that could protect people from the deadly Ebola virus.
17 November 2011
Flu Vaccination Delayed For 'More Advice'
The Department of Health has said on Thursday that it needs further advice from the committee looking into the flu vaccine before it can roll out a larger programme. The announcement follows a request from Health Secretary Andrew Lansley to look at whether the flu vaccination programme should be extended to healthy children.
21 July 2010
HPV Vaccine 'Prolongs Protection' For Genital Warts
Vaccination against certain types of human papillomavirus (HPV) gives strong and sustained protection against genital warts and pre-cancerous growths of the cervix, a new study published on bmj.com has claimed.
04 September 2006
Vaccine could reduce cervical cancer deaths
A new vaccine could help reduce deaths from cervical cancer in the UK by 75%, a study has found. The study examined the effect of the Cervarix vaccine, developed by GlaxoSmithKline. Cervarix targets two of the most common strains of the human papilllomavirus (HPV), which is responsible for around 70% if all cervical cancers.
31 May 2004
Contingency plan for deadly mosquito-borne virus published
A contingency plan to protect the UK against the mosquito-borne disease West Nile Virus has been published by the Chief Medical Officer today. Although the risk of acquiring West Nile Virus infection in the UK has been assessed as low, climate change and long-haul travel could contrive to see the disease spread to Britain.